Trial · NCT04251819
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Pain Threshold | Baseline | Degrees Celsius | MEAN | |
| PRIMARY | Pain Threshold | 1.5 hours post-drug administration during session 2, occurs 7 ± 2 days after baseline visit | Data were missing. | Degrees Celsius | MEAN |
| PRIMARY | Pain Tolerance | Baseline | Degrees Celsius | MEAN | |
| PRIMARY | Pain Tolerance | 1.5 hours post-drug administration during session 2, occurs 7 ± 2 days after baseline visit | Data were missing. | Degrees Celsius | MEAN |
| PRIMARY | Temporal Summation of Pain | Baseline | Data were missing. | units on a scale | MEAN |
| PRIMARY | Temporal Summation of Pain | 1.5 hours post-drug administration during session 2, occurs 7 ± 2 days after baseline visit | Data were missing. | units on a scale | MEAN |
| PRIMARY | Conditioned Pain Modulation | Baseline | Data were missing. | units on a scale | MEAN |
| PRIMARY | Conditioned Pain Modulation | 1.5 hours post-drug administration during session 2, occurs 7 ± 2 days after baseline visit | Data were missing. | units on a scale | MEAN |
| PRIMARY | Suprathreshold Pain Response | Baseline | Data were missing. | units on a scale | MEAN |
| PRIMARY | Suprathreshold Pain Response | 1.5 hours post-drug administration during session 2, occurs 7 ± 2 days after baseline visit | Data were missing. | units on a scale | MEAN |
| SECONDARY | Opioid Symptom Checklist | 30 minutes post-drug administration during session 2, occurs 7 ± 2 days after baseline visit | units on a scale | MEAN | |
| SECONDARY | 26-item Visual Analog Scale (VAS) | 30 minutes post-drug administration during session 2, occurs 7 ± 2 days after baseline visit | units on a scale | MEAN | |
| SECONDARY | Drug Effects Questionnaire-5 | 30 minutes post-drug administration during session 2, occurs 7 ± 2 days after baseline visit | Data were missing. | units on a scale | MEAN |
| SECONDARY | 26-item Visual Analog Scale (Subjective Drug Effects) | 30 minutes post-drug administration during session 2, occurs 7 ± 2 days after baseline visit | units on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04251819/outcomes